PROTEIMER Trademark

Trademark Overview

On Tuesday, October 7, 2025, a trademark application was filed for PROTEIMER with the United States Patent and Trademark Office. The USPTO has given the PROTEIMER trademark a serial number of 99431659. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, October 7, 2025. This trademark is owned by CrossLife Technologies Inc.. The PROTEIMER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biopharmaceutical preparations and therapeutic proteins for medical use, biologic preparations for the treatment of neurological, oncological, metabolic, and immunological disorders, aptamer-based therapeutic agents, protein-based drug candidates and antibody mimetics for medical purposes.

Scientific and technological research and development in the field of biotechnology and pharmaceutical development, research and development of protein-based therapeutics, aptamer-based drug discovery platforms, and biologic drug delivery systems, design and development of biologically active molecules for therapeutic use, providing information in the field of scientific research and development in biotechnology.
proteimer

General Information

Serial Number99431659
Word MarkPROTEIMER
Filing DateTuesday, October 7, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, October 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiopharmaceutical preparations and therapeutic proteins for medical use, biologic preparations for the treatment of neurological, oncological, metabolic, and immunological disorders, aptamer-based therapeutic agents, protein-based drug candidates and antibody mimetics for medical purposes.
Goods and ServicesScientific and technological research and development in the field of biotechnology and pharmaceutical development, research and development of protein-based therapeutics, aptamer-based drug discovery platforms, and biologic drug delivery systems, design and development of biologically active molecules for therapeutic use, providing information in the field of scientific research and development in biotechnology.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 7, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCrossLife Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressCarlsbad 92008
US
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressCarlsbad, CA 92008

Trademark Events

Event DateEvent Description
Tuesday, October 7, 2025NEW APPLICATION ENTERED
Tuesday, October 7, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

proteimer development based research therapeutic drug protein biotechnology field scientific aptamer